TACALYX
Tacalyx, a spin-off from Max-Planck-Institute of Colloids and Interfaces, Potsdam/Germany (MPICI), focuses on Tumor-Associated Carbohydrate Antigens (TACAs) as novel target class for cancer treatment. The highly tumor-specific expression of TACAs results from aberrant glycosylation and promotes metastasis, angiogenesis and suppression of the immune system. Tacalyx uses the sophisticated technology of carbohydrate synthesis to synthesize highly pure TACA structures for the generation and identification of antibodies that will be developed into novel therapeutics for the treatment of cancer.
TACALYX
Social Links:
Industry:
Biotechnology Health Care Life Science Therapeutics
Founded:
2019-01-01
Address:
Berlin, Berlin, Germany
Country:
Germany
Website Url:
http://www.tacalyx.com
Total Employee:
1+
Status:
Active
Contact:
+49 30 407 237 10
Email Addresses:
[email protected]
Total Funding:
14 M EUR
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Euro SPF Google Font API Google Maps SSL By Default IPv6 Apache Microsoft Exchange Online
Similar Organizations
1859
1859 is a biotechnology company focusing on the discovery and development of next-generation therapeutics.
Allinky Biopharma
Allinky Biopharma is a company dedicated to the discovery and development of novel therapeutic agents
AlveoGene
AlveoGene is an innovative company focused on transforming rare respiratory disease outcomes using inhaled gene therapy.
Apeiron Biologics
Apeiron Biologics is a biotech company that focuses on the discovery and development of novel cancer immunotherapies.
D2M Biotherapeutics
D2M Biotherapeutics focuses on the development of novel immunotherapeutics.
Edgewise Therapeutics
Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization.
RNAimmune
RNAimmune is a biopharmaceutical company specializing in the discovery and development of mRNA-based therapeutics and vaccines.
Current Advisors List
Current Employees Featured
Founder
Investors List
Thuja Capital
Thuja Capital investment in Seed Round - Tacalyx
Kurma Partners
Kurma Partners investment in Seed Round - Tacalyx
Creathor Ventures
Creathor Ventures investment in Seed Round - Tacalyx
coparion
coparion investment in Seed Round - Tacalyx
Boehringer Ingelheim Venture Fund
Boehringer Ingelheim Venture Fund investment in Seed Round - Tacalyx
Idinvest Partners
Idinvest Partners investment in Seed Round - Tacalyx
HTGF | High-Tech Gruenderfonds
HTGF | High-Tech Gruenderfonds investment in Seed Round - Tacalyx
Official Site Inspections
http://www.tacalyx.com Semrush global rank: 14.08 M Semrush visits lastest month: 60
- Host name: 217-160-0-104.elastic-ssl.ui-r.com
- IP address: 217.160.0.104
- Location: Germany
- Latitude: 51.2993
- Longitude: 9.491
- Timezone: Europe/Berlin
More informations about "Tacalyx"
Tacalyx - Crunchbase Company Profile & Funding
Tacalyx, a spin-off from Max-Planck-Institute of Colloids and Interfaces, Potsdam/Germany (MPICI), focuses on Tumor-Associated Carbohydrate Antigens (TACAs) as novel target class …See details»
Tacalyx Company Profile - Office Locations, Competitors ... - Craft
Tacalyx is a biotech company that focuses on the discovery and development of novel anti-TACA (tumor-associated carbohydrate antigens) cancer therapies.See details»
Tacalyx Company Profile 2024: Valuation, Funding & Investors
Tacalyx General Information Description. Developer of therapeutics designed to target cancer-specific carbohydrate antigens. The company's therapeutics combine the ability to synthesize …See details»
Tacalyx - Products, Competitors, Financials, Employees, …
Tacalyx is a biotechnology company focused on developing novel anticancer therapeutics in the pharmaceutical industry. Use the CB Insights Platform to explore Tacalyx's full profile. Tacalyx …See details»
TACALYX GmbH Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for TACALYX GmbH of Berlin, Berlin. Get the latest business insights from Dun & Bradstreet.See details»
TACALYX GmbH - Drug pipelines, Patents, Clinical trials - Synapse
Explore TACALYX GmbH with its drug pipeline, therapeutic area, technology platform, 2 news, and 7 literature, Disease Domain:Neoplasms, Technology Platform:Antibody drug conjugate …See details»
Tacalyx - Contacts, Employees, Board Members, Advisors & Alumni
Tacalyx is a biotech company focused on the discovery and development of novel anti-TACASee details»
Tacalyx - Funding, Financials, Valuation & Investors - Crunchbase
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . Jun 11, 2024: Seed Round - …See details»
Tacalyx Company Profile: Overview and Full News Analysis
Tacalyx is a spin-out of the Max-Planck-Institute of Colloids and Interfaces (MPICI) in Potsdam, Germany . The German biotech has established a pipeline of seven novel antibody-based …See details»
Tacalyx - Board Members - The Org
The Board Members at Tacalyx are responsible for providing strategic guidance, overseeing the company's governance, and ensuring the effective execution of its mission to discover and …See details»
Tacalyx - Company Profile - Tracxn
Oct 16, 2024 Tacalyx ranks 341st among 2365 active competitors. 848 of its competitors are funded while 545 have exited. Overall, Tacalyx and its competitors have raised over $79.2B in …See details»
Tacalyx - Startbase
DGAP-News - Tacalyx ernennt Dr. Klaus Schollmeier zum Vorsitzenden des Aufsichtsrats 05.11.2020 - DGAP-News: Tacalyx GmbH / Schlagwort(e): Personalie Tacalyx ernennt Dr. …See details»
Tacalyx Raises €7 Million in Seed Funding to Generate First in Class ...
Tacalyx, a biotech company focused on the discovery and development of novel anti-TACA (Tumor Associated Carbohydrate Antigens) cancer therapies, today announced that it has …See details»
Tacalyx - Crunchbase
Tacalyx is a biotech company focused on the discovery and development of novel anti-TACASee details»
€7 Million to Generate First in Class Anti-TACA Antibodies for …
Sep 26, 2019 Tacalyx, a biotech company focused on the discovery and development of novel anti-TACA (Tumor Associated Carbohydrate Antigens) cancer therapies, announced that it …See details»
Tacalyx - Org Chart, Teams, Culture & Jobs - The Org
View Tacalyx's up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more. This is an unverified company page.See details»
Tacalyx - EU-Startups
Sep 25, 2019 Articles about Tacalyx: June 14, 2024 Weekly funding round-up! All of the European startup funding rounds we tracked this week (June 10 – 14) September 25, 2019 …See details»
Tacalyx - Tech Stack, Apps, Patents & Trademarks - Crunchbase
Nov 10, 2024 Organization. Tacalyx . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Active Tech Count 2. Monthly …See details»
Tacalyx raises seed funding for antibodies for cancer treatment
Sep 25, 2019 Tacalyx secured access to licenses and the know-how from Max-Planck-Innovation GmbH to the underlying technology and related discoveries made by its scientific …See details»